•One-step formulation of PLD using mPEG × HER2 enhanced tumor specificity increased drug internalization and improve the anticancer activity of PLD against HER2-overexpressing and doxorubicin-resistant BCa. The gene discussed is ERBB2; the disease is neoplasm.